reference/31848003

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/31848003

Outgoing Links

Predicate	Object
contentType	Journal Article\|Multicenter Study
issn	2374-2437
issueIdentifier	10
pageRange	e203187-
publicationName	JAMA Oncology
startingPage	e203187
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_8a3ddcc1179cd4b360028558c3ab7cd0 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_15efc6190f3be0fb3582a4f2b162ac6c http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_994afa9810cb30ddf86562b44fafb4b9 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_439eaa3a060cee9558b72b5b44408fde
bibliographicCitation	Cooperberg MR, Zheng Y, Faino AV, Newcomb LF, Zhu K, Cowan JE, Brooks JD, Dash A, Gleave ME, Martin F, Morgan TM, Nelson PS, Thompson IM, Wagner AA, Carroll PR, Lin DW. Tailoring Intensity of Active Surveillance for Low-Risk Prostate Cancer Based on Individualized Prediction of Risk Stability. JAMA Oncol. 2020 Oct 01;6(10):e203187. PMID: 32852532; PMCID: PMC7453344.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0cee0b543434fd92f9b950470942b889 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fee91db344414fe7829f089ca33df7a7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f51620f52af69ceab1689e8be39c5457 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f5d772ae9ea9562d5be9c70561806384 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d08bf03834d16555394b5f04e90c569f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3891dbbf9e66e0fcd347302a7aadbe11 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c6a7aa537a7f4fcb3766b21c520c32cd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_57cb61b5b0f3302cbe34ed05748af8c3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_734b5c625dcc9082a80a6bf23ae611b7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_76f4b4c1af032775aaa1a1d2542aa2b2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_db6a5215ed97dc1c9a78bd201c91389c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cb7d57ddbd3fc2a38362d32d1a9227b8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6b59ca39fbdfbdbe4ae87084aa11447a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_60970449f1c62beea7b56f7f42339831 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_40df825619529e19b4f08715ae8fe517 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f8503e1fbf599dd58d01d42e396fa2f7
date	2020-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/32852532 https://doi.org/10.1001/jamaoncol.2020.3187 https://pubmed.ncbi.nlm.nih.gov/PMC7453344
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/43608 https://portal.issn.org/resource/ISSN/2374-2437
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Tailoring Intensity of Active Surveillance for Low-Risk Prostate Cancer Based on Individualized Prediction of Risk Stability
discusses	http://id.nlm.nih.gov/mesh/M0026444
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D011471Q000473
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D017430Q000097 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D060787 http://id.nlm.nih.gov/mesh/D011446 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D001706 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D012306 http://id.nlm.nih.gov/mesh/D011471Q000097 http://id.nlm.nih.gov/mesh/D011237 http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D000368
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fce276cc0efd2412c7dafdbb1e82fcc8 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6923 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8983

Total number of triples: 56.